Xplico is the market leader in life science valuation, supporting 100+ biotech and pharma companies across Europe, US and Asia in licensing, partnering, fundraising, investments, portfolio management and IPOs.
Xplico offers a range of valuation services from comprehensive reports to well-structured and easy-to-use valuation tools to build your own business cases. The highly specialised analysis and risk assessment are tailored for life science projects, enterprises and cap tables.
Xplico’s tools and services are built on blocks of long experience with real needs of biotech and pharma companies. Established in 2005, Xplico is headquartered in Copenhagen.www.xplico.com